Free · No signup · Updated daily
In Brief
United States removes ad valorem tariffs on specific Indian speciality pharmaceutical products and active ingredients.
The United States has established a zero-tariff regime on selected speciality drugs and active pharmaceutical ingredients imported from India and 19 other nations.
The decision eliminates ad valorem tariffs—which are calculated as a fixed percentage of the monetary value of imported goods—lowering trade barriers for critical pharmaceutical exports.
UAE Signals $25 Billion Investment in India Across Ports, Energy and Space
29 Sep 2026
Govt Widens Investment Scope for Exempted Provident Fund Trusts
28 Sep 2026
Bank Unions Defer Nationwide Strike Following Talks With IBA
28 Sep 2026
Electronics PLI Scheme Beneficiaries Disbursed Rs 19,091 Crore Incentives
28 Sep 2026